Search

everythinglearnresearchcommunity

for

Search:↓

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Higher IL-17A levels indicate more severe alopecia areata.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

More effective treatments are needed for severe alopecia areata.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Higher CRBP1 levels are linked to more severe alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.